2014 Clinical Quality

One of our objectives is to provide you with the information you need to best understand how we're working to provide a healthier population and improved healthcare system. You can use our 2014 reporting data below to compare us to other participating ACOs or compare our performance from year to year. To view more current data, visit our Clinical Quality page.

2014 Reporting Period - Physician's Healthcare Collaborative Quality Measure Results and Comparisons

Measure Number Measure Name ACO Performance Rate Mean Performance Rate (SSP ACOs)
ACO-1 2 Getting Timely Care, Appointments, and Information  74.62 80.13
ACO-2 2 How Well Your Doctors Communicate  91.38 92.39
ACO-3 2 Patients’ Rating of Doctor  91.03 91.58
ACO-4 2 Access to Specialists  84.77 83.97
ACO-5 2 Health Promotion and Education 61.43 58.29
ACO-6 2 Shared Decision Making  75.21 74.60
ACO-7 2 Health Status/Functional Status  72.51 71.10
ACO-8 1 Risk Standardized, All Condition Readmission 14.62 15.15
ACO-9 1 ASC Admissions: COPD or Asthma in Older Adults 0.87 1.08
ACO-10 1 ASC Admission: HF 1.12 1.19
ACO-11 2 Percent of Primary Care Providers Who Successfully Attested for the EHR Incentive Program Incentive Payment 86.49 76.71
ACO-12 2 Medication Reconciliation  53.57 82.61
ACO-13 2 Falls: Screening for Fall Risk  63.26 45.60
ACO-14 2 Influenza Immunization 69.90 57.51
ACO-15 2 Pneumococcal Vaccination 81.35 55.03
ACO-16 2 Adult Weight Screening and Follow-up 58.23 66.75
ACO-17 2 Tobacco Use Assessment and Cessation Intervention 95.88 86.79
ACO-18 2 Depression Screening 41.85 39.27
ACO-19 2 Colorectal Cancer Screening 82.28 56.14
ACO-20 2 Mammography Screening 87.35 61.41
ACO-21 2 Proportion of Adults who had blood pressure screened in past 2 years 43.20 60.24
ACO-22* 2 Hemoglobin A1c Control (HbA1c) (<8 percent)  78.14 Diabetes composite provided only
ACO-23* 2 Low Density Lipoprotein (LDL) (< 100 mg/dL) 70.00 Diabetes composite provided only
ACO-24* 2 Blood Pressure (BP) < 140/90  73.02 Diabetes composite provided only
ACO-25* 2 Tobacco Non-Use  83.49 Diabetes composite provided only
ACO-26* 2 Aspirin Use  76.47 Diabetes composite provided only
ACO-27 1 Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) 9.07 20.35
ACO-28 2 Percent of beneficiaries with hypertension whose BP < 140/90 70.47 68.02
ACO-29 2 Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl 71.39 57.29
ACO-30 2 Percent of beneficiaries who use Aspirin or other antithrombotic 84.13 80.79
ACO-31 2 Beta-Blocker Therapy for LVSD 83.74 82.71
ACO-32* 2 Drug Therapy for Lowering LDL-Cholesterol 80.82 CAD composite provided only
ACO-33* 2 (ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) 72.15 CAD composite provided only

1 The lower the percentage the better the performance.
2 The higher the percentage the better the performance.

* - Measure is part of either the Diabetes Composite measure or the Coronary Artery Disease Composite measure